Key Insights

Highlights

Success Rate

50% trial completion

Treatment Research

2 treatments under study, led by Silent Hip

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 55/100

Termination Rate

50.0%

1 terminated out of 2 trials

Success Rate

50.0%

-36.6% vs benchmark

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results50% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 3 (1)

Trial Status

Completed1
Terminated1

Trial Success Rate

50.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT01383824Not ApplicableTerminated

A Multi-centre Study to Assess the Long-term Performance of the Silent Hip™ in Primary Total Hip Replacement Surgery

NCT00765362Phase 3Completed

Mobile - Bearing Knee Study

Showing all 2 trials

Research Network

Common Treatments

  • Silent Hip1
  • Encore Mobilebearing Knee1

Active Sponsors

  • Encore Medical, L.P.1
  • DePuy International1

Related Conditions

  • Osteoarthritis1
  • Inflammatory Tissue Disorder1
  • Avascular Necrosis1
  • Posttraumatic Arthritis1
  • Primary Arthritis1

Activity Timeline